HEADER TRANSCRIPTION REGULATION 17-AUG-06 2J2S TITLE SOLUTION STRUCTURE OF THE NONMETHYL-CPG-BINDING CXXC DOMAIN OF THE TITLE 2 LEUKAEMIA-ASSOCIATED MLL HISTONE METHYLTRANSFERASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ZINC FINGER PROTEIN HRX; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1146-1214; COMPND 5 SYNONYM: ALL-1, TRITHORAX-LIKE PROTEIN, CXXC DOMAIN OF MLL-1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: TUNER; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PRSETA (MODIFIED) KEYWDS TRANSCRIPTION REGULATION, CHROMOSOMAL REARRANGEMENT, ZINC-FINGER, KEYWDS 2 DNA-BINDING, BROMODOMAIN, POLYMORPHISM, MIXED LINEAGE LEUKAEMIA, KEYWDS 3 ZINC BINDING, TRANSCRIPTION, METAL-BINDING, ZINC, CXXC, MBD1, HOX KEYWDS 4 GENES, CHROMATIN, METHYLATION, PROTO-ONCOGENE, NUCLEAR PROTEIN, KEYWDS 5 PHOSPHORYLATION, CPG DINUCLEOTIDE, ALTERNATIVE SPLICING EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.D.ALLEN,C.G.GRUMMITT,C.HILCENKO,S.YOUNG-MIN,L.M.TONKIN,C.M.JOHNSON, AUTHOR 2 M.BYCROFT,A.J.WARREN REVDAT 5 19-APR-17 2J2S 1 REMARK REVDAT 4 24-FEB-09 2J2S 1 VERSN REVDAT 3 20-DEC-06 2J2S 1 JRNL REVDAT 2 27-SEP-06 2J2S 1 JRNL REVDAT 1 21-AUG-06 2J2S 0 JRNL AUTH M.D.ALLEN,C.G.GRUMMITT,C.HILCENKO,S.Y.MIN,L.M.TONKIN, JRNL AUTH 2 C.M.JOHNSON,S.M.FREUND,M.BYCROFT,A.J.WARREN JRNL TITL SOLUTION STRUCTURE OF THE NONMETHYL-CPG-BINDING CXXC DOMAIN JRNL TITL 2 OF THE LEUKAEMIA-ASSOCIATED MLL HISTONE METHYLTRANSFERASE JRNL REF EMBO J. V. 25 4503 2006 JRNL REFN ISSN 0261-4189 JRNL PMID 16990798 JRNL DOI 10.1038/SJ.EMBOJ.7601340 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE REMARK 4 REMARK 4 2J2S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-AUG-06. REMARK 100 THE PDBE ID CODE IS EBI-29736. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 290.0 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 90% WATER, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AMX; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ANSIG REMARK 210 METHOD USED : CNS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : NO VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR REMARK 210 SPECTROSCOPY ON 13C, 15N-LABELED CXXC DOMAIN REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLU 1143 TO GLY REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PRO 1144 TO GLY REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PRO 1145 TO SER REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A1147 -67.60 -135.69 REMARK 500 1 LYS A1148 30.12 -98.47 REMARK 500 1 GLN A1157 25.04 -154.96 REMARK 500 1 VAL A1169 -6.21 -144.01 REMARK 500 1 ARG A1182 17.55 -148.20 REMARK 500 1 LYS A1186 70.02 15.15 REMARK 500 1 LYS A1208 -178.05 -63.20 REMARK 500 1 ALA A1210 36.76 -146.68 REMARK 500 2 GLN A1157 26.77 -154.78 REMARK 500 2 VAL A1169 -6.54 -144.63 REMARK 500 2 ARG A1182 17.52 -148.65 REMARK 500 2 ASN A1183 19.46 58.31 REMARK 500 2 LYS A1186 85.58 16.38 REMARK 500 2 TYR A1205 -90.52 42.65 REMARK 500 2 ALA A1212 156.61 59.47 REMARK 500 2 VAL A1213 -46.31 -152.30 REMARK 500 3 SER A1145 82.63 -69.36 REMARK 500 3 LYS A1147 161.55 59.47 REMARK 500 3 GLN A1157 27.70 -155.22 REMARK 500 3 VAL A1169 -12.24 -141.61 REMARK 500 3 ARG A1182 19.77 -153.19 REMARK 500 3 LYS A1186 61.69 15.91 REMARK 500 3 LYS A1203 40.12 -106.64 REMARK 500 4 GLN A1157 32.77 -156.56 REMARK 500 4 VAL A1169 -7.64 -144.68 REMARK 500 4 ARG A1182 18.34 -146.28 REMARK 500 4 LYS A1186 72.42 12.74 REMARK 500 4 ALA A1204 86.01 71.13 REMARK 500 4 GLN A1207 -67.74 68.92 REMARK 500 5 LYS A1147 -75.67 -156.50 REMARK 500 5 GLN A1157 21.48 -153.40 REMARK 500 5 ASN A1183 17.71 58.77 REMARK 500 5 LYS A1186 81.43 17.84 REMARK 500 5 TYR A1205 -89.61 41.04 REMARK 500 5 GLN A1209 -78.18 -160.34 REMARK 500 6 GLN A1157 24.66 -153.54 REMARK 500 6 VAL A1169 -2.99 -145.03 REMARK 500 6 LYS A1186 87.83 25.65 REMARK 500 6 SER A1202 170.71 57.24 REMARK 500 6 LYS A1211 56.61 -119.62 REMARK 500 6 ALA A1212 -77.71 -152.19 REMARK 500 6 VAL A1213 83.71 -62.61 REMARK 500 7 SER A1145 -77.32 -92.78 REMARK 500 7 LYS A1147 145.89 169.79 REMARK 500 7 GLN A1157 22.69 -152.87 REMARK 500 7 VAL A1169 -7.79 -143.91 REMARK 500 7 LYS A1186 81.18 31.99 REMARK 500 7 TYR A1205 -89.99 41.37 REMARK 500 7 ALA A1210 76.83 -106.89 REMARK 500 7 ALA A1212 -72.47 -84.33 REMARK 500 REMARK 500 THIS ENTRY HAS 160 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A2215 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1173 SG REMARK 620 2 CYS A1170 SG 102.9 REMARK 620 3 CYS A1189 SG 97.8 123.9 REMARK 620 4 CYS A1167 SG 109.7 106.2 114.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A2216 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1161 SG REMARK 620 2 CYS A1155 SG 126.8 REMARK 620 3 CYS A1158 SG 116.5 100.9 REMARK 620 4 CYS A1194 SG 105.7 103.2 100.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A2215 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A2216 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AGH RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR COOPERATIVE TRANSCRIPTION FACTORBINDING TO THE REMARK 900 CBP COACTIVATOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTATIONS AT THE N-TERMINUS ARE REQUIRED FOR REMOVAL OF REMARK 999 FUSION PROTEIN. GLY 1143-SER 1145 REQUIRED FOR PURIFICATION. DBREF 2J2S A 1143 1214 UNP Q03164 HRX_HUMAN 1143 1214 SEQADV 2J2S GLY A 1143 UNP Q03164 GLU 1143 ENGINEERED MUTATION SEQADV 2J2S GLY A 1144 UNP Q03164 PRO 1144 ENGINEERED MUTATION SEQADV 2J2S SER A 1145 UNP Q03164 PRO 1145 ENGINEERED MUTATION SEQRES 1 A 72 GLY GLY SER VAL LYS LYS GLY ARG ARG SER ARG ARG CYS SEQRES 2 A 72 GLY GLN CYS PRO GLY CYS GLN VAL PRO GLU ASP CYS GLY SEQRES 3 A 72 VAL CYS THR ASN CYS LEU ASP LYS PRO LYS PHE GLY GLY SEQRES 4 A 72 ARG ASN ILE LYS LYS GLN CYS CYS LYS MET ARG LYS CYS SEQRES 5 A 72 GLN ASN LEU GLN TRP MET PRO SER LYS ALA TYR LEU GLN SEQRES 6 A 72 LYS GLN ALA LYS ALA VAL LYS HET ZN A2215 1 HET ZN A2216 1 HETNAM ZN ZINC ION FORMUL 2 ZN 2(ZN 2+) HELIX 1 1 CYS A 1170 ASP A 1175 1 6 HELIX 2 2 LYS A 1176 GLY A 1180 5 5 SHEET 1 AA 2 ARG A1151 ARG A1154 0 SHEET 2 AA 2 LEU A1197 MET A1200 -1 O GLN A1198 N ARG A1153 LINK ZN ZN A2215 SG CYS A1173 1555 1555 2.29 LINK ZN ZN A2215 SG CYS A1170 1555 1555 2.21 LINK ZN ZN A2215 SG CYS A1189 1555 1555 2.35 LINK ZN ZN A2215 SG CYS A1167 1555 1555 2.20 LINK ZN ZN A2216 SG CYS A1161 1555 1555 2.22 LINK ZN ZN A2216 SG CYS A1155 1555 1555 2.30 LINK ZN ZN A2216 SG CYS A1158 1555 1555 2.27 LINK ZN ZN A2216 SG CYS A1194 1555 1555 2.35 SITE 1 AC1 4 CYS A1167 CYS A1170 CYS A1173 CYS A1189 SITE 1 AC2 6 CYS A1155 GLY A1156 CYS A1158 CYS A1161 SITE 2 AC2 6 CYS A1194 ASN A1196 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1